Pavlovian conditioned approach with different reward magnitudes reveals opposing effects of acute and chronic semaglutide treatment
- 1University of Michigan
Abstract
Rationale: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have attracted interest for their effects on motivational processes beyond satiation and weight loss, including motivation for drug rewards. Reward-predictive cues can acquire motivational value and promote food- and drug-seeking, raising the possibility that GLP-1RAs affect intake by altering cue-motivated behavior. Preclinical studies report reduced food intake and responding for drug rewards following GLP-1RA treatment. However, many preclinical studies have used acute treatment; whereas, clinically, GLP1-RAs are administered as chronic treatments with dose escalation to mitigate adverse effects. Objectives: Using a modified Pavlovian conditioned approach (PavCA) paradigm, we directly compared the effects of acute and chronic semaglutide treatment on conditioned approach behavior elicited by cues predicting different magnitudes of palatable food reward in male and female rats. Results: Although both treatment regimens reduced body weight relative to vehicle treatment, chronic semaglutide increased, whereas acute semaglutide decreased, sign-tracking toward reward-associated cues. Rats exhibited greater sign-tracking toward cues predicting large versus small rewards, but semaglutide did not differentially alter this reward-magnitude effect. Acutely treated rats consumed fewer reward pellets and exhibited less food-cup activity during non-cue periods. These findings suggest that nonspecific behavioral suppression or malaise may have contributed to reduced responding after acute treatment. Conclusions: The effects of semaglutide on cue-motivated behavior depend on the treatment regimen. Acute-treatment studies should be interpreted cautiously because adverse or nonspecific effects may contribute to apparent reductions in motivation.
Related
- Extended Pavlovian conditioned approach training and devaluation in Long-Evans rats using time-restricted feeding
- Chronic semaglutide treatment attenuates cue-induced reinstatement of cocaine-seeking and cocaine-induced stereotypy in male and female rats
- Active Escape or Active Change? Decomposing Pavlovian Bias into Non-emotional Components
- Acute fentanyl induces opposing directions of changes in tonic and phasic dopamine release patterns and impairs Pavlovian task performance
- Environmental volatility amplifies Pavlovian control in decision-making
BibTeX
@misc{desrochers2026pavlovian,
title = {{Pavlovian conditioned approach with different reward magnitudes reveals opposing effects of acute and chronic semaglutide treatment}},
author = {S. S. Desrochers and R. Li and S. B. Flagel},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.08.750149},
url = {https://www.biorxiv.org/content/10.64898/2026.09.08.750149v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Pavlovian conditioned approach with different reward magnitudes reveals opposing effects of acute and chronic semaglutide treatment
AU - S. S. Desrochers
AU - R. Li
AU - S. B. Flagel
PY - 2026
DA - 2026/09/08
PB - bioRxiv
DO - 10.64898/2026.09.08.750149
UR - https://www.biorxiv.org/content/10.64898/2026.09.08.750149v1
AB - Rationale: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have attracted interest for their effects on motivational processes beyond satiation and weight loss, including motivation for drug rewards. Reward-predictive cues can acquire motivational value and promote food- and drug-seeking, raising the possibility that GLP-1RAs affect intake by altering cue-motivated behavior. Preclinical studies report reduced food intake and responding for drug rewards following GLP-1RA treatment. However, many preclinical studies have used acute treatment; whereas, clinically, GLP1-RAs are administered as chronic treatments with dose escalation to mitigate adverse effects. Objectives: Using a modified Pavlovian conditioned approach (PavCA) paradigm, we directly compared the effects of acute and chronic semaglutide treatment on conditioned approach behavior elicited by cues predicting different magnitudes of palatable food reward in male and female rats. Results: Although both treatment regimens reduced body weight relative to vehicle treatment, chronic semaglutide increased, whereas acute semaglutide decreased, sign-tracking toward reward-associated cues. Rats exhibited greater sign-tracking toward cues predicting large versus small rewards, but semaglutide did not differentially alter this reward-magnitude effect. Acutely treated rats consumed fewer reward pellets and exhibited less food-cup activity during non-cue periods. These findings suggest that nonspecific behavioral suppression or malaise may have contributed to reduced responding after acute treatment. Conclusions: The effects of semaglutide on cue-motivated behavior depend on the treatment regimen. Acute-treatment studies should be interpreted cautiously because adverse or nonspecific effects may contribute to apparent reductions in motivation.
ER -